October 28, 2011 article Open access Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model Anesthesiology DOI: 10.1097/aln.0b013e318238c036 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 246 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Comparing Hemostatic Efficacy of Four-factor Prothrombin Complex Concentrate with Andexanet Alfa in an Apixaban-treated Polytrauma Male Porcine Model 2026 Anesthesiology article Medicine Trauma, Hemostasis, Coagulopathy, Resuscitation Open access 1 citations Reversing Rivaroxaban Anticoagulation as Part of a Multimodal Hemostatic Intervention in a Polytrauma Animal Model 2021 Anesthesiology article Medicine Trauma, Hemostasis, Coagulopathy, Resuscitation 11 citations Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies 2020 Seminars in Thrombosis and Hemostasis article Medicine Blood Coagulation and Thrombosis Mechanisms Open access 15 citations 3 results References 0